financetom
Business
financetom
/
Business
/
Beyond Meat Stock Slips, Traders Chew On Q3 Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Beyond Meat Stock Slips, Traders Chew On Q3 Estimates
Oct 24, 2025 10:01 AM

Beyond Meat, Inc. ( BYND ) shares slipped Friday as investors looked to the company's freshly released preliminary third-quarter results to pull the stock back up. 

Here's a look at what Beyond Meat ( BYND ) said to expect when it releases its Q3 earnings report on Nov. 4. 

BYND stock is down. See the real-time price action here. 

The purveyor of fake meats expects about $70 million in sales, consistent with earlier guidance of $68 million to $73 million. The figure indicates stable short-term performance, though not necessarily growth. 

Read Next: Latest Beyond Meat Short-Seller? Martin Shkreli, Of Course

Gross margins are expected to be 10% to 11%, including $1.7 million in costs associated with shutting down operations in China. Without those costs, margins improve to 12–13%.

Beyond Meat ( BYND ) also expects a large non-cash impairment, meaning the book value of some long-term assets (factories, equipment, etc.) is higher than what they’re worth and those assets must be "written down."

The company admits that the charge will be material (significant), but they do not yet know the exact amount.

Overall, preliminary results show modest revenue, but continued pressure on profitability and costs, especially from exiting China and asset impairments. 

Investors should view the results as evidence that Beyond Meat ( BYND ) is still restructuring and continues to face challenges. 

The company is set to release its third-quarter financial results after the closing bell on Nov. 4. Analysts expect Beyond Meat ( BYND ) to report a loss of 43 cents per share and revenue of $68.87 million, according to Benzinga Pro estimates. 

BYND Price Action: Beyond Meat ( BYND ) shares were down 8.27% at $2.60 at the time of publication on Friday, but were holding gains of 300% for the week.

Read Next: 

Rigetti, D-Wave, IonQ Could Get JPMorgan’s Support—Quantum Stocks Take Off

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
May 26, 2025
08:51 AM EDT, 05/23/2025 (MT Newswires) -- Consumer stocks were mixed premarket Friday as the Consumer Staples Select Sector SPDR Fund (XLP) was up 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) declined by 2.0% recently. MINISO Group Holding ( MNSO ) shares fell past 16% after the company reported a decline in Q1 adjusted earnings. ...
Canadians Continue to Head to The Stores to Shop, Notes CIBC
Canadians Continue to Head to The Stores to Shop, Notes CIBC
May 26, 2025
08:56 AM EDT, 05/23/2025 (MT Newswires) -- Canadian consumers haven't tightened the purse strings much it seems, in the face of tariff uncertainty, said CIBC. Headline retail sales posted a solid 0.8% month-over-month advance in March (while consensus +was for a 0.7% rise, although that was largely driven by auto sales which may have been bolstered by households choosing to...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Crescita Announces Mutual Termination of Agreement With Croma Pharma for Pliaglis
Crescita Announces Mutual Termination of Agreement With Croma Pharma for Pliaglis
May 26, 2025
08:52 AM EDT, 05/23/2025 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) on Friday said the agreement granting German company Croma Pharma exclusive rights to market Pliaglis, a topical local anaesthetic cream, in select European countries has been terminated by mutual agreement. Crescita will regain all development and commercialization rights for Pliaglis in Europe while Croma will pay Crescita $900,000....
Copyright 2023-2026 - www.financetom.com All Rights Reserved